News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,499 Results
Type
Article (1038)
Company Profile (4)
Press Release (39457)
Section
Business (11609)
Career Advice (44)
Deals (1658)
Drug Delivery (5)
Drug Development (2833)
Employer Resources (6)
FDA (563)
Job Trends (746)
News (15274)
Policy (793)
Tag
Academia (73)
Accelerated approval (16)
ADA (11)
Allergies (43)
Alliances (854)
ALS (67)
Alzheimer's disease (197)
Antibody-drug conjugate (ADC) (190)
Approvals (918)
Artificial intelligence (300)
ASCO (96)
Autoimmune disease (118)
Automation (30)
Bankruptcy (4)
Best Places to Work (917)
BIO (19)
Biologics (4)
BIOSECURE Act (1)
Biosimilars (83)
BioSpace Insights (6)
Biotechnology (5)
Bladder cancer (125)
Brain cancer (14)
Breast cancer (322)
Cancer (2272)
Cardiovascular disease (166)
Career advice (39)
Career pathing (3)
CAR-T (91)
CDC (3)
CDMO (4)
Celiac Disease (1)
Cell therapy (265)
Cervical cancer (21)
Clinical research (5151)
Collaboration (852)
Commercialization (2)
Compensation (569)
Complete response letters (12)
COVID-19 (154)
CRISPR (46)
C-suite (445)
Cystic fibrosis (42)
Data (2877)
Decentralized trials (1)
Denatured (3)
Depression (32)
Dermatology (46)
Diabetes (125)
Diagnostics (667)
Digital health (15)
Diversity (1)
Drug discovery (131)
Drug pricing (21)
Drug shortages (3)
Duchenne muscular dystrophy (85)
Earnings (13386)
Editorial (3)
Employer resources (4)
Events (5880)
Executive appointments (470)
FDA (2028)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (10)
Funding (655)
Gene editing (87)
Generative AI (18)
Gene therapy (209)
GLP-1 (142)
Government (137)
Grass and pollen (3)
Guidances (214)
Healthcare (1003)
Hematology (48)
HIV (51)
Huntington's disease (17)
IgA nephropathy (34)
Immunology and inflammation (40)
Immuno-oncology (32)
Indications (75)
Infectious disease (252)
Inflammatory bowel disease (46)
Inflation Reduction Act (3)
Influenza (33)
Intellectual property (67)
Interviews (6)
IPO (1396)
IRA (3)
Job creations (71)
Job search strategy (30)
Kidney cancer (15)
Labor market (7)
Layoffs (20)
Leadership (1)
Legal (146)
Licensing (6)
Liver cancer (27)
Longevity (6)
Lung cancer (341)
Lymphoma (176)
Machine learning (25)
Management (4)
Manufacturing (309)
Marketing (6)
MASH (36)
Medical affairs (1)
Medical device (960)
Medtech (1027)
Mergers & acquisitions (733)
Metabolic disorders (285)
mRNA (30)
Multiple sclerosis (59)
NASH (1)
Neurodegenerative disease (146)
Neuropsychiatric disorders (28)
Neuroscience (666)
NextGen: Class of 2026 (183)
Non-profit (111)
Now hiring (4)
Obesity (122)
Opinion (9)
Ovarian cancer (72)
Pain (50)
Pancreatic cancer (82)
Parkinson's disease (100)
Partnered (1)
Patents (131)
Patient recruitment (276)
Peanut (14)
People (2028)
Peptides (2)
Pharmaceutical (1)
Pharmacy benefit managers (8)
Phase 1 (1354)
Phase 2 (2047)
Phase 3 (2121)
Pipeline (3905)
Policy (12)
Postmarket research (101)
Preclinical (473)
Prostate cancer (135)
Psychedelics (5)
Radiopharmaceuticals (266)
Rare diseases (343)
Real estate (91)
Recruiting (3)
Regulatory (2008)
Reports (6)
Research institute (105)
Resumes & cover letters (6)
Rett syndrome (33)
RNA editing (4)
RSV (35)
Schizophrenia (49)
Series A (103)
Series B (88)
Sickle cell disease (32)
Special edition (4)
Spinal muscular atrophy (10)
Sponsored (2)
Startups (67)
Stomach cancer (2)
Supply chain (37)
Tariffs (2)
The Weekly (1)
Vaccines (179)
Venture capital (17)
Weight loss (50)
Women's health (42)
Worklife (1)
Date
Last 7 days (149)
Last 30 days (508)
Last 365 days (9258)
2026 (6603)
2025 (9326)
2024 (5375)
2023 (2119)
2022 (2395)
2021 (2236)
2020 (1951)
2019 (1560)
2018 (1186)
2017 (968)
2016 (728)
2015 (926)
2014 (582)
2013 (397)
2012 (490)
2011 (517)
2010 (431)
Location
Africa (28)
Alabama (8)
Arizona (35)
Arkansas (4)
Asia (2414)
Australia (254)
California (5222)
Canada (839)
China (348)
Colorado (178)
Connecticut (224)
Delaware (272)
Europe (6275)
Florida (514)
Georgia (103)
Hawaii (4)
Idaho (5)
Illinois (469)
India (30)
Indiana (93)
Iowa (12)
Japan (349)
Kansas (10)
Kentucky (11)
Louisiana (21)
Maine (11)
Maryland (408)
Massachusetts (3771)
Michigan (94)
Minnesota (216)
Mississippi (1)
Missouri (59)
Montana (2)
Nebraska (3)
Nevada (59)
New Hampshire (16)
New Jersey (1242)
New Mexico (7)
New York (1170)
North Carolina (446)
North Dakota (3)
Northern California (2651)
Ohio (162)
Oklahoma (9)
Oregon (10)
Pennsylvania (564)
Puerto Rico (5)
Rhode Island (11)
South America (38)
South Carolina (8)
Southern California (2006)
Tennessee (90)
Texas (815)
United States (16456)
Utah (84)
Virginia (141)
Washington D.C. (16)
Washington State (374)
West Virginia (1)
Wisconsin (115)
40,499 Results for "93".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Moleculin Announces Pricing of $9.3 Million Public Offering
August 2, 2026
·
5 min read
Press Releases
Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML
September 3, 2026
·
7 min read
Funding
Memento brings home $93M series A souvenir, picks up bispecific for eye diseases
Memento’s lead asset is a bispecific antibody that blocks VEGF and activates Tie2. The biotech plans to test the candidate in retinal conditions such as neovascular age-related macular degeneration and diabetic macular edema.
June 19, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Belay Diagnostics Summit™ Informed Clinical Decisions in 93% of Cases in Large Real-World CNS Study
May 6, 2026
·
3 min read
Press Releases
Memento Medicines Launches with $93 Million Series A Financing to advance Tie2 Agonist and VEGF Inhibitor Bispecific Antibody Therapy for Retinal Diseases
June 19, 2026
·
7 min read
Press Releases
Generic Sterile Injectables Market Size to worth USD 93.39 Billion by 2032, says Coherent Market Insights
October 3, 2025
·
1 min read
Press Releases
Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies
April 28, 2026
·
3 min read
Venture Capitalists
Novo-Backed Oral Medicine Biotech Adds Lilly to Investors in $93M Series A
Orbis emerged from stealth in February 2024 with $28.1 million in seed funding. The Danish biotech, which aims to flip biologics into oral medicines, has now raised another $93 million.
January 6, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Antiverse Raises $9.3M Series A to Develop Antibodies for Undruggable Disease Targets and Announces Research Agreement with the Cystic Fibrosis Foundation
March 3, 2026
·
4 min read
Press Releases
Nocion Therapeutics Extends Series B Financing to $93 Million to Support Late-Stage Development of Taplucainium in Chronic Cough
January 8, 2026
·
3 min read
1 of 4,050
Next
